Neurofibromatosis Type 1 and the Search for Effective Tumor Therapies Using High-Throughput Drug Screening.
Simple Summary: In this review, we examine five decades of drug screening efforts aimed at developing treatments for Neurofibromatosis Type 1 (NF1). We begin with an overview of the clinical manifestations of NF1, followed by a discussion of early attempts to target the RAS pathway before the advent...
| Publicado en: | Current Oncology Vol. 32; no. 11; pp. 649 - 699 |
|---|---|
| Autores principales: | , , |
| Formato: | Journal Article |
| Publicado: |
MDPI
Nov2025
|
| Acceso en línea: | Ver este registro en EBSCOhost |